Sudden cardiac death and inherited channelopathy: The basic electrophysiology of the myocyte and myocardium in ion channel disease

Heart

Volumn 98, Issue 7, 2012, Pages 536-543

  Martin, Claire A ^a   Matthews, Gareth D K ^a   Huang, Christopher L H ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANKYRIN; CALSEQUESTRIN; CAVEOLIN 3; ION CHANNEL; POTASSIUM CHANNEL KCNE1; POTASSIUM CHANNEL KCNE2; POTASSIUM CHANNEL KCNQ1; RYANODINE RECEPTOR 2; SODIUM CALCIUM EXCHANGE PROTEIN; SODIUM CHANNEL NAV1.5;

BRUGADA SYNDROME; CARDIAC CHANNELOPATHY; CASQ2 GENE; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; ELECTROCARDIOGRAPHY; EXPERIMENTAL MODEL; GENE; GENE MUTATION; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HEART MUSCLE CELL; HEART MUSCLE FIBER MEMBRANE POTENTIAL; HUMAN; LONG QT SYNDROME; MEDICAL RESEARCH; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROGRESSIVE CARDIAC CONDUCTION DEFECT; REVIEW; RISK ASSESSMENT; RYR2 GENE; SCN5A GENE; SUDDEN DEATH;

ANIMALS; ARRHYTHMIAS, CARDIAC; CHANNELOPATHIES; DEATH, SUDDEN, CARDIAC; ELECTROPHYSIOLOGICAL PHENOMENA; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ION CHANNELS; MUTATION; MYOCYTES, CARDIAC;

EID: 84863349113     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2011-300953     Document Type: Review

References (59)

1. Kannel WB, Kannel C, Paffenbarger RS Jr, et al. Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 1987;113:1489-94. (Pubitemid 17092823)
2. National Institute for Health and Clinical Excellence. Implantable cardioverter defibrillators for arrhythmias. TA095. London: National Institute for Health and Clinical Excellence (2006). http://www.nice.org.uk/ourguidance/ reference.jsp
3. Gallagher PJ. The pathological investigation of sudden cardiac death. Curr Diagn Pathol 2007;13:366-74. (Pubitemid 47379547)
4. Bastiaenen R, Behr ER. Sudden death and ion channel disease: pathophysiology and implications for management. Heart 2011;97:1365-72.
5. Nunn LM, Lambiase PD. Genetics and cardiovascular diseasedcauses and prevention of unexpected sudden adult death: the role of the SADS clinic. Heart 2011;97:1122-7.
6. Behr E, Bastiaenen R. Early repolarisation: controversies and clinical implications. Heart 2012; In press.
7. Antzelevitch C, Brugada P, Brugada J, et al. Brugada syndrome: 1992-2002: a historical perspective. J Am Coll Cardiol 2003;41:1665-71. (Pubitemid 36584232)
8. 2+ channel agonist Bay K 8644. Circ Res 1988;62:563-71.
9. 2+ activation are common defects of RyR2 mutations linked to ventricular tachycardia and sudden death. Circ Res 2005;97:1173-81.
10. Mines G. On circulating excitations in heart muscles and their possible relation to tachycardia and fibrillation. Trans R Soc Can 1914;8:43-52.
11. Hessen SE, Michelson EL. Mechanisms of Ventricular arrhythmias: from laboratory to bedside. ACC Curr J Rev 1994;4:11-16.
12. Chauhan VS, Downar E, Nanthakumar K, et al. Increased ventricular repolarization heterogeneity in patients with ventricular arrhythmia vulnerability and cardiomyopathy: a human in vivo study. Am J Physiol Heart Circ Physiol 2006;290:H79-86.
13. Morita H, Zipes DP, Fukushima-Kusano K, et al. Repolarization heterogeneity in the right ventricular outflow tract: correlation with ventricular arrhythmias in Brugada patients and in an in vitro canine Brugada model. Heart Rhythm 2008;5:725-33.
14. Martin CA, Grace AA, Huang CL. Spatial and temporal heterogeneities are localized to the right ventricular outflow tract in a heterozygotic Scn5a mouse model. Am J Physiol Heart Circ Physiol 2011;300:H605-16.
15. Kurita T, Shimizu W, Inagaki M, et al. The electrophysiologic mechanism of ST-segment elevation in Brugada syndrome. J Am Coll Cardiol 2002;40:330-4. (Pubitemid 34756296)
16. Rosenbaum DS, Jackson LE, Smith JM, et al. Electrical alternans and vulnerability to ventricular arrhythmias. N Engl J Med 1994;330:235-41. (Pubitemid 24034135)
17. Pastore JM, Girouard SD, Laurita KR, et al. Mechanism linking T-wave alternans to the genesis of cardiac fibrillation. Circulation 1999;99:1385-94. (Pubitemid 29129926)
18. Nolasco JB, Dahlen RW. A graphic method for the study of alternation in cardiac action potentials. J Appl Physiol 1968;25:191-6.
19. Moss AJ, Kass RS. Long QT syndrome: from channels to cardiac arrhythmias. J Clin Invest 2005;115:2018-24. (Pubitemid 41134137)
20. Sabir IN, Li LM, Jones VJ, et al. Criteria for arrhythmogenicity in genetically-modified Langendorff-perfused murine hearts modelling the congenital long QT syndrome type 3 and the Brugada syndrome. Pflugers Arch 2008;455:637-51. (Pubitemid 350160478)
21. Matthews GD, Martin CA, Grace AA, et al. Regional variations in action potential alternans in isolated murine Scn5a+/- hearts during dynamic pacing. Acta Physiol (Oxf) 2010;2:129-46.
22. + channel function in mice: what have we learned, and where do we go from here? Circ Res 2001;89:944-56.
23. Rentschler S, Vaidya DM, Tamaddon H, et al. Visualization and functional characterization of the developing murine cardiac conduction system. Development 2001;128:1785-92. (Pubitemid 32514858)
24. Knollmann BC, Katchman AN, Franz MR. Monophasic action potential recordings from intact mouse heart: validation, regional heterogeneity, and relation to refractoriness. J Cardiovasc Electrophysiol 2001;12:1286-94. (Pubitemid 33111899)
25. Fabritz L, Kirchhof P, Franz MR, et al. Prolonged action potential durations, increased dispersion of repolarization, and polymorphic ventricular tachycardia in a mouse model of proarrhythmia. Basic Res Cardiol 2003;98:25-32. (Pubitemid 36163514)
26. Liu G, Iden JB, Kovithavongs K, et al. In vivo temporal and spatial distribution of depolarization and repolarization and the illusive murine T wave. J Physiol 2004;555:267-79. (Pubitemid 38313076)
27. Thomas G, Killeen MJ, Gurung IS, et al. Mechanisms of ventricular arrhythmogenesis in mice following targeted disruption of KCNE1. J Physiol 2006;578:97-114.
28. Salama G, London B. Mouse models of long QT syndrome. J Physiol 2007;578:43-53. (Pubitemid 44971109)
29. Stokoe KS, Thomas G, Goddard CA, et al. Effects of flecainide and quinidine on arrhythmogenic properties of Scn5a+/Δ murine hearts modelling long QT syndrome 3. J Physiol 2007;578:69-84. (Pubitemid 44971111)
30. Martin CA, Zhang Y, Grace AA, et al. Increased right ventricular repolarization gradients promote arrhythmogenesis in a murine model of Brugada Syndrome. J Cardiovasc Electrophysiol 2010;21:1153-9.
31. Liu N, Colombi B, Memmi M, et al. Arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia: insights from a RyR2 R4496C knock-in mouse model. Circ Res 2006;99:292-8. (Pubitemid 44174937)
32. Yan GX, Antzelevitch C. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation. Circulation 1999;100:1660-6. (Pubitemid 29477277)
33. Shimizu W, Aiba T, Kurita T, et al. Paradoxic abbreviation of repolarization in epicardium of the right ventricular outflow tract during augmentation of Brugada-type ST segment elevation. J Cardiovasc Electrophysiol 2001;12:1418-21. (Pubitemid 34073224)
34. Meregalli PG, Wilde AA, Tan HL. Pathophysiological mechanisms of Brugada syndrome: depolarization disorder, repolarization disorder, or more? Cardiovasc Res 2005;67:367-78. (Pubitemid 41019546)
35. Tukkie R, Sogaard P, Vleugels J, et al. Delay in right ventricular activation contributes to Brugada syndrome. Circulation 2004;109:1272-7. (Pubitemid 38372786)
36. Eckardt L, Bruns HJ, Paul M, et al. Body surface area of ST elevation and the presence of late potentials correlate to the inducibility of ventricular tachyarrhythmias in Brugada syndrome. J Cardiovasc Electrophysiol 2002;13:742-9. (Pubitemid 34921131)
37. Coronel R, Casini S, Koopmann TT, et al. Right ventricular fibrosis and conduction delay in a patient with clinical signs of Brugada syndrome: a combined electrophysiological, genetic, histopathologic, and computational study. Circulation 2005;112:2769-77. (Pubitemid 41641670)
38. Nademanee K, Veerakul G, Chandanamattha P, et al. Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium. Circulation 2011;123:1270-9.
39. Lambiase PD, Ahmed AK, Ciaccio EJ, et al. High-density substrate mapping in Brugada syndrome: combined role of conduction and repolarization heterogeneities in arrhythmogenesis. Circulation 2009;120:106-17, 1-4.
40. Martin CA, Guzadhur L, Grace AA, et al. Mapping of reentrant spontaneous polymorphic ventricular tachycardia in a Scn5a+/- mouse model. Am J Physiol Heart Circ Physiol 2011;300:H1853-62.
41. Morita H, Zipes DP, Lopshire J, et al. T wave alternans in an in vitro canine tissue model of Brugada syndrome. Am J Physiol Heart Circ Physiol 2006;291:H421-8.
42. van Veen TA, Stein M, Royer A, et al. Impaired impulse propagation in Scn5a-knockout mice: combined contribution of excitability, connexin expression, and tissue architecture in relation to aging. Circulation 2005;112:1927-35. (Pubitemid 41377410)
43. Thomas G, Killeen MJ, Grace AA, et al. Pharmacological separation of early afterdepolarizations from arrhythmogenic substrate in ΔKPQ Scn5a murine hearts modelling human long QT 3 syndrome. Acta Physiol (Oxf) 2008;192:505-17. (Pubitemid 351322725)
44. Fabritz L, Damke D, Emmerich M, et al. Autonomic modulation and antiarrhythmic therapy in a model of long QT syndrome type 3. Cardiovasc Res 2010;87:60-72.
45. Marks AR, Priori S, Memmi M, et al. Involvement of the cardiac ryanodine receptor/ calcium release channel in catecholaminergic polymorphic ventricular tachycardia. J Cell Physiol 2002;190:1-6.
46. Lahat H, Eldar M, Levy-Nissenbaum E, et al. Autosomal recessive catecholamine- or exercise-induced polymorphic ventricular tachycardia: clinical features and assignment of the disease gene to chromosome 1p13-21. Circulation 2001;103:2822-7. (Pubitemid 32550071)
47. Leenhardt A, Lucet V, Denjoy I, et al. Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation 1995;91:1512-19.
48. Cerrone M, Noujaim SF, Tolkacheva EG, et al. Arrhythmogenic mechanisms in a mouse model of catecholaminergic polymorphic ventricular tachycardia. Circ Res 2007;101:1039-48. (Pubitemid 350084981)
49. Cerrone M, Colombi B, Santoro M, et al. Bidirectional ventricular tachycardia and fibrillation elicited in a knock-in mouse model carrier of a mutation in the cardiac ryanodine receptor. Circ Res 2005;96:e77-82.
50. Lehnart SE, Wehrens XH, Laitinen PJ, et al. Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak. Circulation 2004;109:3208-14.
51. 2+ release, and catecholaminergic polymorphic ventricular tachycardia. J Clin Invest 2006;116:2510-20.
52. Brugada R, Hong K, Dumaine R, et al. Sudden death associated with short-QT syndrome linked to mutations in HERG. Circulation 2004;109:30-5. (Pubitemid 38056017)
53. Antzelevitch C, Pollevick GD, Cordeiro JM, et al. Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation 2007;115:442-9. (Pubitemid 46184195)
54. Extramiana F, Antzelevitch C. Amplified transmural dispersion of repolarization as the basis for arrhythmogenesis in a canine ventricular-wedge model of short-QT syndrome. Circulation 2004;110:3661-6. (Pubitemid 39665254)
55. Mehta M, Jain AC, Mehta A. Early repolarization. Clin Cardiol 1999;22:59-65. (Pubitemid 29077392)
56. Yan GX, Antzelevitch C. Cellular basis for the electrocardiographic J wave. Circulation 1996;93:372-9. (Pubitemid 26031498)
57. Burashnikov E, Pfeiffer R, Barajas-Martinez H, et al. Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death. Heart Rhythm 2010;7:1872-82.
58. Haissaguerre M, Chatel S, Sacher F, et al. Ventricular fibrillation with prominent early repolarization associated with a rare variant of KCNJ8/KATP channel. J Cardiovasc Electrophysiol 2009;20:93-8.
59. Grant AO, Carboni MP, Neplioueva V, et al. Long QT syndrome, Brugada syndrome, and conduction system disease are linked to a single sodium channel mutation. J Clin Invest 2002;110:1201-9. (Pubitemid 35215901)